Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Brooklyn ImmunoTherapeutics, Inc. | Financial_Report.xls |
| EX-31.2 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3102.htm |
| EX-10.5 - INDEMNIFICATION AGREEMENT - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex1005.htm |
| EX-32.1 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3201.htm |
| EX-10.3 - SEPARATION AGREEMENT - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex1003.htm |
| EX-10.1 - EMPLOYMENT AGREEMENT - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex1001.htm |
| EX-31.1 - CERTIFICATION - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex3101.htm |
| EX-10.2 - TRANSITION AGREEMENT - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex1002.htm |
| EX-10.4B - INDUCEMENT PLAN - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex1004b.htm |
| EX-10.4A - INDUCEMENT PLAN - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-ex1004a.htm |
| 10-Q - FORM 10-Q - Brooklyn ImmunoTherapeutics, Inc. | ntn_10q-093014.htm |
Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of NTN Buzztime, Inc. (the “Registrant”) on Form 10-Q for the period ended September 30, 2014 (the “Report”), I, Sandra Gurrola, Vice President of Finance of the Registrant, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
| Dated: November 7, 2014 | /s/ Sandra Gurrola |
| Sandra Gurrola | |
| Vice President of Finance | |
| NTN Buzztime, Inc. |